Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Remyelination”

35 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 35 results

Large-scale testing (Phase 3)Study completedNCT03774407
What this trial is testing

Vaginal Estriol in Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic Bladder
Texas Tech University Health Sciences Center 21
Large-scale testing (Phase 3)Study completedNCT04626921
What this trial is testing

A Multi-Center, Open-Label Long-Term Extension Study of CNM-Au8 In Patients With Stable Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Multiple Sclerosis
Clene Nanomedicine 55
Not applicableStudy completedNCT05783934
What this trial is testing

Demyelination and Remyelination in Multiple Sclerosis (MS) Detected by Brain Amyloid PET-CT

Who this might be right for
Multiple Sclerosis
Istituti Clinici Scientifici Maugeri SpA 6
Early research (Phase 1)Study completedNCT06683612
What this trial is testing

PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary FibrosisMultiple Sclerosis+6 more
Contineum Therapeutics 16
Large-scale testing (Phase 3)Looking for participantsNCT05338450
What this trial is testing

Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple Sclerosis

Who this might be right for
Multiple SclerosisInternuclear Ophthalmoplegia
Amsterdam UMC, location VUmc 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06330077
What this trial is testing

Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRemitting Relapsing Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Study completedNCT04539002
What this trial is testing

Aerobic Exercise for Remyelination in Multiple Sclerosis

Who this might be right for
Multiple SclerosisSclerosisDemyelinating Diseases+4 more
Oregon Health and Science University 60
Not applicableLooking for participantsNCT06641271
What this trial is testing

Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis
University of Colorado, Denver 70
Large-scale testing (Phase 3)Study completedNCT01307332
What this trial is testing

Advanced MRI Measures of Repair in Alemtuzumab Treated Patients

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of British Columbia 27
Not applicableLooking for participantsNCT06796504
What this trial is testing

The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

Who this might be right for
Relapsing Remitting Multiple Sclerosis
SetPoint Medical Corporation 60
Testing effectiveness (Phase 2)Study completedNCT02493049
What this trial is testing

Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of Calgary 17
Not applicableUnknownNCT01918501
What this trial is testing

Testing Mitochondria Activity and Blood Lipid Content of Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Ziv Hospital 120
Testing effectiveness (Phase 2)Study completedNCT01772199
What this trial is testing

Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 131
Testing effectiveness (Phase 2)Study completedNCT04002934
What this trial is testing

Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Riley Bove, MD 63
Testing effectiveness (Phase 2)Looking for participantsNCT07304024
What this trial is testing

A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound

Who this might be right for
Central Auditory Processing DisorderHearing Impaired (Partially)Hearing+23 more
University of Colorado, Denver 344
Not applicableUnknownNCT04042363
What this trial is testing

Effect of Transorbital Electrical STIMulation of Optic Nerve on Remyelination After an Acute Optic Neuritis

Who this might be right for
Multiple SclerosisOptic Neuritis
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 45
Testing effectiveness (Phase 2)Ended earlyNCT03222973
What this trial is testing

Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Biogen 263
Testing effectiveness (Phase 2)Looking for participantsNCT04121468
What this trial is testing

A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)
The Hospital for Sick Children 20
Testing effectiveness (Phase 2)Study completedNCT05131828
What this trial is testing

CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy

Who this might be right for
Multiple Sclerosis
Cambridge University Hospitals NHS Foundation Trust 70
Not applicableUnknownNCT05147532
What this trial is testing

Remyelination in Multiple Sclerosis: a PET-MR Longitudinal Study Investigating Individual Profiles of Myelin Repair and the Contribution of Neuroinflammation

Who this might be right for
Multiple SclerosisInflammatory Disease
Assistance Publique - Hôpitaux de Paris 80
Load More Results